Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia

FASEB Journal

Volumn 20, Issue 7, 2006, Pages

  Gigante, Bruna ^a   Morlino, Giulia ^a   Gentile, Maria Teresa ^b   Persico, Maria Graziella ^a   De Falco, Sandro ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Hindlimb ischemia; Macrophage infiltration; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; NOS3 PROTEIN, MOUSE; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CAPILLARY DENSITY; CONTROLLED STUDY; GENE DELETION; IMMUNOHISTOCHEMISTRY; LEG ISCHEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TIME; VASCULARIZATION;

ANIMALIA;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISCHEMIA; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PHENOTYPE; PREGNANCY PROTEINS; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 33845667407     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4481fje     Document Type: Article

References (39)

1. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat. Med. 9, 653-660
2. Simons, M., and Ware, J. A. (2003) Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2, 863-871
3. De Falco, S., Gigante, B., and Persico, M. G. (2002) Structure and function of placental growth factor. Trends Cardiovasc. Med. 12, 241-246
4. Gigante, B., Tarsitano, M., Cimini, V., De Falco, S., and Persico, M. G. (2004) Placenta growth factor is not required for exercise-induced angiogenesis. Angiogenesis 7, 277-284
5. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) Synergism between VEGF and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583
6. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. (1994) Placenta growth factor. Potentiation of VEGF bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25,646-25,654
7. Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9, 936-943
8. Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840
9. Epstein, S. E., Kornowski, R., Fuchs, S., and Dvorak, H. F. (2001) Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115-119
10. Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A., and Sessa, W. C. (1997) Nitric oxide production contributes to the angiogenic properties of VEGF in human endothelial cells. J. Clin. Invest. 100, 3131-3139
11. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., and Bicknell, R. (1997) Nitric oxide synthase lies downstream from VEGF-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99, 2625-2634
12. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., Huang, P. L., and Isner, J. M. (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567-2578
13. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
14. Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., and Fishman, M. C. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242
15. Shesely, E. G., Maeda, N., Kim, H. Statistical Packages for the Social Sciences., Desai, K. M., Krege, J. H., Laubach, V. E., Sherman, P. A., Sessa, W. C., and Smithies, O. (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 93, 13,176-13,181
16. Steudel, W., Ichinose, F., Huang, P. L., Hurford, W. E., Jones, R. C., Bevan, J. A., Fishman, M. C., and Zapol, W. M. (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ. Res. 81, 34-41
17. Shen, B. Q., Lee, D. Y., and Zioncheck, T. F. (1999) VEGF governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J. Biol. Chem. 274, 33,057-33,063
18. Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C. O., Buerk, D. G., Huang, P. L., and Jain, R. K. (2001) Predominant role of endothelial nitric oxide synthase in VEGF-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U. S. A. 98, 2604-2609
19. Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., and Ahmed, A. (2001) VEGF receptor-1 modulates VEGF-mediated angiogenesis via nitric oxide. Am. J. Pathol. 159, 993-1008
20. Tsurumi, Y., Murohara, T., Krasinski, K., Chen, D., Witzenbichler, B., Kearney, M., Couffinhal, T., and Isner, J. M. (1997) Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat. Med. 3, 879-886
21. Namba, T., Koike, H., Murakami, K., Aoki, M., Makino, H., Hashiya, N., Ogihara, T., Kaneda, Y., Kohno, M., and Morishita, R. (2003) Angiogenesis induced by endothelial nitric oxide synthase gene through VEGF expression in a rat hindlimb ischemia model. Circulation 108, 2250-2257
22. Ramanathan, M., Giladi, A., and Leibovich, S. J. (2003) Regulation of VEGF gene expression in murine macrophages by nitric oxide and hypoxia. Exp. Biol. Med. (Maywood) 228, 697-705
23. Su, Y. R., Linton, M. F., and Fazio, S. (2002) Rapid quantification of murine avidin-biotin complex mRNAs by real time reverse transcriptase-polymerase chain reaction. J. Lipid Res. 43, 2180-2187
24. Errico, M., Riccioni, T., Iyer, S., Pisano, C., Acharya, K. R., Persico, M. G., and De Falco, S. (2004) Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor. J. Biol. Chem. 279, 43,929-43,939
25. Arras, M., Ito, W. D., Scholz, D., Winkler, B., Schaper, J., and Schaper, W. (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101, 40-50
26. Williams, S. M., Haines, J. L., and Moore, J. H. (2004) The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings? Bioessays 26, 170-179
27. Pipp, F., Heil, M., Issbrucker, K., Ziegelhoeffer, T., Martin, S., van den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P., et al. (2003) VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92, 378-385
28. Hiratsuka, S., Nakao, K., Nakamura, K., Katsuki, M., Maru, Y., and Shibuya, M. (2005) Membrane fixation of VEGF receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol. Cell. Biol. 25, 346-354
29. Ferdinandy, P., and Schulz, R. (2003) Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138, 532-543
30. Griendling, K. K., and FitzGerald, G. A. (2003) Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912-1916
31. Radi, R. (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U. S. A. 101, 4003-4008
32. Poon, B. Y., Raharjo, E., Patel, K. D., Tavener, S., and Kubes, P. (2003) Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity. Circulation 108, 1107-1112
33. Richard, D. E., Berra, E., and Pouyssegur, J. (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275, 26,765-26,771
34. Khatri, J. J., Johnson, C., Magid, R., Lessner, S. M., Laude, K. M., Dikalov, S. I., Harrison, D. G., Sung, H. J., Rong, Y., and Galis, Z. S. (2004) Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109, 520-525
35. Zhu, X. Y., Rodriguez-Porcel, M., Bentley, M. D., Chade, A. R., Sica, V., Napoli, C., Caplice, N., Ritman, E. L., Lerman, A., and Lerman, L. O. (2004) Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109, 2109-2115
36. Westenfeld, R., Gawlik, A., de Heer, E., Kitahara, M., Abou-Rebyeh, F., Floege, J., and Ketteler, M. (2002) Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis. Kidney Int 61, 834-838
37. Amano, K., Matsubara, H., Iba, O., Okigaki, M., Fujiyama, S., Imada, T., Kojima, H., Nozawa, Y., Kawashima, S., Yokoyama, M., and Iwasaka, T. (2003) Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41, 156-162
38. Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L., and Brown, M. S. (1994) The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low-density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. U. S. A. 91, 4431-4435
39. Bonthu, S., Heistad, D. D., Chappell, D. A., Lamping, K. G., and Faraci, F. M. (1997) Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 17, 2333-2340